Finance

Lists
TRVI:NASDAQ
Trevi Therapeutics Inc
$ 13.56
-1.81%
(-0.25) 1D
$ 13.56
0.00% (0.00)
After hours
Closed: 10-р сарын 30, 16:00:00 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TRVI...
Open
$ 13.52
High
$ 13.91
Low
$ 13.44
Mkt. cap
1.93 тэрбум
Avg. vol.
2.42 сая
Volume
1.73 сая
52-wk high
$ 20.15
52-wk low
$ 9.84
EPS
-$ 0.34
Beta
0.98
Shares outstanding
142.48 сая
No. of employees
34
Open
$ 13.52
High
$ 13.91
Low
$ 13.44
Mkt. cap
1.93 тэрбум
Avg. vol.
2.42 сая
Volume
1.73 сая
52-wk high
$ 20.15
52-wk low
$ 9.84
EPS
-$ 0.34
Beta
0.98
Shares outstanding
142.48 сая
No. of employees
34
News stories
From web sources and news partners
The Globe and Mail
The Globe and Mail
·
1 цагийн өмнө
Annovis Bio Addresses NYSE Non-Compliance Listing Notice
MarketWatch
MarketWatch
·
1 өдрийн өмнө
The selloff in tech stocks is shifting into overdrive
About Trevi Therapeutics Inc
CEO-
Employees34
Founded2011
HeadquartersНью Хэйвен, Коннектикут, Америкийн Нэгдсэн Улс
SectorPharmaceutical industry
Analyst ratings
Based on 10 analysts giving stock ratings to TRVI in the past 3 months
Strong buy
Buy
10
Hold
0
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for TRVI in the last 3 months.
Highest
Current $ 13.56
$ 40.00 (+194.99%)
Average
$ 29.00 (+113.86%)
Lowest
$ 23.00 (+69.62%)
Analyst
Recommendation
Action
Price target
Projected
Date
Debanjana Chatterjee
JonesTrading
Buy
Maintained
$ 28.00
+106.5%
10/22/2026
Conor MacKay
BMO Capital
Buy
Maintained
$ 36.00
+165.5%
10/06/2026
Brandon Folkes
H.C. Wainwright
Buy
Maintained
$ 24.00
+77%
09/21/2026
Judah Frommer
Morgan Stanley
Buy
Reiterated
$ 23.00
+69.6%
08/10/2026
Serge Belanger
Needham
Buy
Maintained
$ 23.00
+69.6%
08/07/2026
Ryan Deschner
Raymond James
Buy
Maintained
$ 40.00
+195%
08/07/2026
Mayank Mamtani
B. Riley Securities
Buy
Initiated
$ 31.00
+128.6%
08/07/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Reiterated
$ 30.00
+121.2%
08/06/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
$ 25.00
+84.4%
08/07/2026
Annabel Samimy
Stifel Nicolaus
Buy
Reiterated
$ 30.00
+121.2%
08/07/2026
Evan Seigerman
BMO Capital
Buy
Initiated
$ 36.00
+165.5%
07/21/2026
Unknown Analyst
BMO Capital
Buy
Initiated
$ 36.00
+165.5%
07/20/2026
William Wood
B. Riley Securities
Buy
Reiterated
$ 31.00
+128.6%
07/17/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
$ 29.00
+113.9%
05/07/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
10.08 сая
6.19 сая
9.94 сая
15.15 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.83 сая
4.03 сая
4.97 сая
5.36 сая
Operating expense
13.92 сая
10.22 сая
14.91 сая
20.51 сая
Total operating expenses
13.92 сая
10.22 сая
14.91 сая
20.51 сая
Operating income
-13.92 сая
-10.22 сая
-14.91 сая
-20.51 сая
Other non operating income
-2.00 мян
-15.00 мян
-
-
EBT including unusual items
-11.82 сая
-8.33 сая
-13.21 сая
-17.82 сая
EBT excluding unusual items
-11.82 сая
-8.33 сая
-13.21 сая
-17.82 сая
Income tax expense
-15.00 мян
-16.00 мян
-20.00 мян
-19.00 мян
Effective tax rate
0.13%
0.19%
0.15%
0.11%
Other operating expenses
-
-
-
-
Net income
-11.80 сая
-8.32 сая
-13.19 сая
-17.80 сая
Net profit margin
-
-
-
-
Earnings per share
-0.08
-0.06
-0.09
-0.11
Interest and investment income
2.10 сая
1.90 сая
1.70 сая
2.70 сая
Interest expense
-
-
-
-
Net interest expenses
2.10 сая
1.90 сая
1.70 сая
2.70 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
-13.88 сая
-10.19 сая
-14.88 сая
-20.48 сая
Gain or loss from assets sale
-
7.00 мян
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google аппс